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Introduction: We continuously look for new techniques to improve the radicality of resection
and to eliminate the negative effects of surgery. One of the methods that has been
implemented in the perioperative management of Cushing's disease was the combination
of three magnetic resonance imaging (MRI) sequences: SE, SPGR and fSPGR.
Material and methods: We enrolled 41 patients (11 males, 30 females) diagnosed with Cush-
ing's disease. A 3D tumour model with a navigation console was developed using each SPGR,
fSPGR and SE sequence. The largest model was then used. In all cases, a standard four-
handed, bi-nostril endoscopic endonasal technique was used. Endocrinological follow-up
evaluation using morning cortisol sampling was performed for 6–34 months in our study.
Results: In total, 36 patients (88%) were disease-free following surgery. Our results indicate
we achieved 100% sensitivity of MR. Overall, the conformity of at least one donor site, as
compared with the places designated on MR, was in 78% of patients. We searched the place
of compliance in individual locations. There is a consensus in individual locations in 63 of
the 123 cases (or 56%). The correlation gamma function at a 5% signiﬁcance level was then
0.27.
Discussion: The combination of MR sequences (SE, SPGR, fSPGR), neuronavigation system
and iMRI led to increased sensitivity of up to 100%. Speciﬁcity reached 56% in our study.
Conclusion: We found a high success rate in surgical procedure in terms of the correlation
between MR ﬁndings and histology, which leads to remission of Cushing's disease.
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Cushing's disease or central Cushing's syndrome is a condition
of an increase in cortisone in the blood level caused by a benign
pituitary tumour secreting adrenocorticotropic hormone
(ACTH). In 1910, Harvey Cushing performed the ﬁrst trans-
sphenoidal surgery for pituitary adenoma using sublabial
incision [1,2]. However, in 1925, Cushing replaced the
transsphenoidal approach with the transcranial approach.
Cushing's disease was ﬁrst described by Harvey Cushing in
1932 [3]. Since then, pituitary surgery has undergone consid-
erable development. The sublabial transsphenoidal approach
was not forgotten largely thanks to the work of N. Dott and G.
Guiot. The ﬁrst transsphenoidal surgery in the Central Military
Hospital in Prague was performed by E. Černý in 1972. In May
2006, an endoscopic mononostril technique was introduced at
Neurosurgical Department of 1st Medical Faculty of Charles
University. Since November 2006, a binostril endoscopic
technique was employed and since April 2008, intraoperative
magnetic resonance imaging (iMRI) has been used. We keep
looking for new techniques to improve the radicality of
resection, as well as to eliminate negative effects of surgery.
One of the methods, that was implemented in the periopera-
tive management of Cushing's disease, was the combination
of three magnetic resonance imaging (MRI) sequences (SE –
spine echo, SPGR – spoiled gradient recalled acquisition in
steady state and fSPGR – fast spoiled gradient recalled
acquisition). Tumour identiﬁcation sensitivity of the SPGR
sequence alone is 76% and speciﬁcity 33% [4]. The aim of our
study was to correlate sensitivity and speciﬁcity of combined
MRI with histological ﬁndings.
2. Material and methods
2.1. Cohort characteristics
We enrolled 41 patients (30 males, 11 females) diagnosed with
Cushing's disease. The average age at the time of diagnosis
was 40 years (range 8–78 years). The average age of males was
42 years (range 20–69 years) and of the females 40 years (range
8–78 years). Tumour dimensions were measured using
neuronavigation software BrainLabTM. The average volume
of the tumours was 444 mm3 (range 4–3078 mm3). If we deﬁne
microadenoma as a tumour smaller than 524 mm3, 36 patients
had microadenoma and 5 had macroadenomas in our cohort.
Endocrinological follow-up using morning cortisol sam-
pling was 6–34 months.
2.2. Biopsy samples collection
BrainLab iPLAN NET software was used during the whole
surgery. Before surgery, the navigation SPGR sequence with
gadolinium enhancement was uploaded to the navigation
console. A 3D tumour model was designed using each
sequence (i.e. SPGR, fSPGR and SE). The protocol consisted
of following sequences. fSPGR 3D:fast AX 3D T1W sekvence TR
7 ms, TE 4–5 ms, prep time 450 ms, ﬂip angle 208, NEX 2, slice
1 mm, matrix 256 (freq)  512 (phase), FOV 25.6 cm, locs perslab 50, frequency enc. direction AP, scanning time 11:05. SPGR
3D:AX 3D T1W sekvence TR 23 ms, TE 6–11 ms, ﬂip angle 208,
NEX 1, slice 1.6 mm, matrix 256  256, FOV 25.6 cm, locs per
slab 60, frequency enc. direction AP, scanning time 4:02. SAG
contrast enhanced T1W: 2D Fast SE sekvence (FSE-XL) TR
420 ms, TE 15 ms, ﬂip angle 908, ETL 4, NEX 4, slice thicness
2 mm, matrix 384  224, FOV 14 cm, 12 slices, frequency enc.
direction SI, 10 ml Multihance (Bracco Diagnostic Inc., USA) i.v.,
scanning time 3:12.
Each MRI was reviewed three times: intial analysis was
performed by the radiologist who was on duty on the date of
the investigation. The second review was done by the
experienced neurosurgeon who was not performing the
surgery but has got extensive experience with sellar region
analysis on MRI. The third analysis was performed by
neuroradiologist with special experience and interest in
neuroimaging. Data underwent the ﬁnal review, tumour
volume was depicted and sent into the navigation system.
The Sella turcica was divided horizontally into thirds and
labelled zone I (central third), II (left third) and III (right
third) (Fig. 1). During surgery, a biopsy sample of minimum
diameter (0.50) mm was carefully collected from each zone
(I, II, III), leaving healthy adenohypophysis intact (Fig. 2). If
healthy adenohypophysis were in the zone of biopsy, a
sample from the nearest point was collected. After biopsy
samples were harvested, the rest of the tumour was
resected using a neuronavigation 3D model. The site of
histological specimen removal was stored in navigation
system in order to analyse the distance of the histological
specimen removal and pituitary adenoma according to
preoperative MRI.
Standard analysis of histological specimen was performed.
Following investigations were performed: hematoxyllin-eosin
stain, Wilderś reticulin stain and immunohistochemical stain
for ACTH.
2.3. Surgical technique
All patients underwent surgery under general anaesthesia. In
all cases, a standard four-handed, bi-nostril endoscopic
endonasal technique was used. In the sella region, a rigid
endoscope with 08 optics Karl Storz (180/4 mm), a high-
deﬁnition HD camera and an Aesculap LED light source were
employed. A surgical intradural technique is identical to
microscopic surgery. We used blunt dissectors as well as sharp
curettes. Eventual bleeding was controlled with haemostatic
foam in order to keep good access to the biopsy zones. We tried
to identify both tumour and adenohypophysis by endoscope
and neuronavigation. In all patients, 3.0T iMRI was performed.
Standard MRI follow-up was scheduled on postoperative day 1,
day 90 (3 months), 9 months after and then periodically once a
year.
3. Results
(A) Disease remission during the follow-up period and
correlation between MRI and histology
(1) In total, 36 patients (88%) were disease-free after
surgery.
Fig. 1 – Plan – free thirds.
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ings (i.e. all sites positive according to MRI were
positive according to histology and vice versa, all
negative sites according to MRI were negative accord-
ing to histology) occurred in 8 cases (20%). In these 8
cases, disease remission was achieved in all 8 patients
and the morning cortisol level was 23–462 mmol/l
(Fig. 3).
(3) No agreement between MRI ﬁndings and histology (i.e.
there was a different adenoma location than according
to MRI) was observed in 9 patients (22%).
(4) The agreement on one point or more but not a
complete match between MRI sites of adenoma and
histological ﬁndings occurred in 24 patients (58%).
Overall, the conformity of at least one donor site, in
comparison with the places designated (the sum of the
full match and at least one point of compliance) on MRI,
occurred in 78% of the patients.
(a) Larger histology ﬁndings than those displayed on
the MRI (i.e. there were positive samples from
peripheral areas outside the ﬁndings displayed on
MRI – tumour exceeded the area shown on MRI byhistology) was observed in 21 patients, i.e. 51%. In
case of histology ﬁndings larger than the ﬁndings
displayed on the MRI, then normalisation of
morning serum cortisol level was observed at 19
in 21 patients (i.e. 90%). In these cases serum
cortisol was between 6 nmol/L and 551 nmol/L in
the follow-up period. Surgery was unsuccessful in
two patients with histological ﬁndings exceeding
the MRI ﬁndings. Their endocrinological levels were
649 nmol/L and 870 nmol/L.
There were 8 cases of full concordance of MRI
and histological ﬁndings and 21 cases when
histology was exceeding the MRI ﬁndings.
Endocrinological remission was achieved in 27
patients out of 29 these patients (93%) (Figs. 4 and 5).
(b) Less extensive histology ﬁndings (i.e. there were
negative samples taken in place of MRI ﬁndings)
were found in three patients (7%). If the histology
were less extensive (i.e. there were negative
samples taken in place of MRI ﬁndings or not any
positive sample), then there was endocrinological
remission in 1 of the 3 cases (33%) (Figs. 6 and 7).
Full  ag ree ment between  MRI ﬁn dings 
and histol ogy
agre ement
disagreement
Fig. 4 – Match between magnetic resonance imaging
findings and histological evaluation.
Exnc on ac vity  in cas e of l ess 
extensive histol ogy
radical
paral
Fig. 7 – Extinction morning serum cortisol activity in case of
less extensive histology findings than magnetic resonance
imaging findings in the follow-up period.
Fig. 3 – Full agreement between magnetic resonance
imaging findings and histological evaluation.
Fig. 2 – MR after surgery – histology I, II, III.
Agreement  between MRI ﬁndings  an d 
histol ogy
full agreeme nt
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less  ext. h istology
disagreeme nt
Fig. 5 – Match between magnetic resonance imaging
findings and histological evaluation – more detail.
Exnc on ac vity  in cas e of a 
con formity or larger histology
radic al
paral
Fig. 6 – Extinction morning serum cortisol activity in case of
conformity or larger histology findings than magnetic
resonance imaging findings in the follow-up period.
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MRI and histological ﬁndings.
Each sampling area was shared and compared with similar
areas of histological positivity for statistical calculations. We
searched places of consensus in various areas (Table 1).
There is a consensus in individual locations in 63 of the 123
cases, i.e. 56%, as seen from Table 2.
Correlation gamma at the 5% signiﬁcance level was then
0.27. Full compliance (i.e. all combinations consensus) was
reached in only 20% per cent of cases (Table 3).
Table 2 – The correlation gamma of a conformity of
individual measuring points according to MRI and
histology findings.
Gamm correlation (correlation)
CHD dropped in pairs
Ref. Correlations are signiﬁcant in the hl. p < .05000
MR Histology
1.000000 0.272727
0.272727 1.000000
Table 1 – PivotTable on the agreement between MRI and
histology findings.
PivotTable (correlation)
The frequency of labelled cells > 10 (marginal totals are
not labelled)
MR Histology Histology Line totals
0 1
0 20 40 60
1 14 49 63
All groups 34 89 123
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In 1910, Harvey Cushing performed the ﬁrst transsphenoidal
surgery for pituitary adenoma using sublabial incision [1,2]. In
1925, Cushing replaced the transsphenoidal approach with the
transcranial approach. The sublabial transsphenoidal approach
continued to be used because of the work of N. Dott and G. Guiot.
Dott and Guiot not only adopted the transsphenoidal technique
but also introduced intraoperative ﬂuoroscopy. In the same
period, J. Hardy made an important breakthrough in pituitary
surgery using an operative microscope, which led to the
resurrection of the sublabial approach [5].
The ﬁrst transsphenoidal pituitary surgery in the Central
Military Hospital in Prague was performed by E. Černý in 1972.
This technique was later improved by I. Fuks and eventually
became a standard procedure [6]. In May 2006, the endoscopic
endonasal mononostril approach was introduced in the
Neurosurgical Department of the 1st Medical Faculty of
Charles University. Since November 2006, the binostril
endoscopic endonasal technique was employed [7]. The arrival
of intraoperative magnetic resonance imaging (iMRI) in April
2008 enabled increased radicality in pituitary surgery [8,9].
Four therapeutic modalities are currently available for
sellar lesions: observation, neurosurgery, pharmacologicalTable 3 – Complete agreement of all three combinations.
Category Table of freque
Frequency Cumulative frequency 
0 33 33 
1 8 41 
ChD 0 41 treatment and radiosurgery (Leksell Gamma Knife (LGK) is
used in the Czech Republic). These four modalities are more
complementary than they are contradictory. Modern surgical
techniques clearly lead to increased radicality and a decrease
in adverse effects [10].
Radicality is of great importance when evaluating any
surgical procedure; in the case of hormonal active adenomas,
radicality is deﬁned as a hormone level decrease. To achieve
higher radicality, new diagnostic methods are available. For
Cushing's disease, diagnosis and adenoma localisation and
selective cavernous sinus catheterisation were used. One of
the largest studies that tried to show an advantage of
cavernous sinus catheterisation over MRI occurred over 20
years ago, in 1994. This paper included 20 patients: catheter-
isation was unsuccessful in three (12%) of the 20 patients.
Concordance of lateralisation of sinus sampling and tumour
localisation during surgery were observed in 7 out of 11 (64%)
patients without corticotropin-releasing hormone (CRH) stim-
ulation and in 8 out of 11 (73%) patients after CRH stimulation.
In 3 out of 12 (25%) patients, lateralisation changed after CRH
stimulation [11]. Catheterisation is no longer in practise today
because of the arrival of modern imaging techniques such as
MRI, computed tomography (CT), positron emission tomogra-
phy (PET) and sonography.
One study concerning sonographic diagnosis examined 68
patients with negative or inconclusive MRI results. Intraop-
erative ultrasonography identiﬁed tumours in 47 (69%)
patients with a negative MRI ﬁnding. In three of these 47
patients, no tumour was found by the pathologist in the
biopsy sample. Considering the difﬁcult implementation of
ultrasound in the surgical process and the need for relatively
extensive skills, sonography offers only a more precise
localisation of the tumour, but cannot measure the extent
and size of the lesion [12]. Based on the above-mentioned
data, the best diagnostic option is MRI with an SPGR sequence.
One recent paper compared the sequence MRI SPGR, MRI SE
and high-resolution positron emission tomography (hrPET).
Ten patients were included in that study. MRI identiﬁed
adenoma in four (40%) patients using SE and in seven (70%)
patients using SPGR.
18F-ﬂuorodeoxyglucose (F-FDG) hrPET diagnosed adenoma
in four (40%) patients with tumour size 3–14 mm. Thus, hrPET
was able to identify small, hormonally active adenomas in
Cushing's disease better than SE MRI but not better than SPGR
MRI [13]. In conclusion, SPGR MRI thus far is the most effective
diagnostic method in Cushing's disease. What is still unknown
is whether SPGR is precise enough to allow surgery.
As stated earlier in this paper, SPGR identiﬁes adenoma
very well. We do not know how speciﬁc and precise it is in
diagnosing the extent of adenoma. We must keep in mind thatncies: a pair of grey (data)
Relative frequency Cumulative relative frequency
80.48780 80.4878
19.51220 100.0000
0.00000 100.0000
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without any clinical signs [14,15]. In other words, 10% of the
population might harbour a hormonally active adenoma in
addition to an inactive tumour. However, according to a large
series of 660 patients, only 2% had Cushing's disease [16].
Gradient-echo MRI sequences could be divided into the
spoiled gradient-echo and steady-state free precession (SSFP)
sequence. SPGR or spoiled GRASS are among the spoiled
gradient-echo sequences. In this group belongs also fasts PGR,
which is an extremely low angle shot. Before the discovery of
SPGR, some researchers tried to improve diagnostics using
double perfusion of pituitary adenomas from the hypophy-
seal portal system and the meningohypophyseal trunk in
conjunction with dynamic scanning after the application of a
contrast agent. These studies showed no signiﬁcant improve-
ment over conventional MRI [17,18]. SPGR was ﬁrst used in
1990 to diagnose Cushing's disease in six patients. Sensitivity
was found to be 80% [19]. In another paper assessing
diagnostic value in 76 prolactinoma patients, sensitivity
was 75%, but only 15 had a surgically conﬁrmed tumour in the
depicted region. These patients were those in which hor-
monal treatment failed [20]. It obviously led to some
scepticism on the diagnostic value of SPGR. Many factors
are responsible for the seemingly excellent sensitivity and
diagnostic precision of SPGR when compared with standard
MRI [21–24].
The important question remains as to whether SPGR is a
suitable tool to plan the extent of resection. In the largest study
from 2003 that examined 50 surgical patients. The authors
concluded that using SPGR during the planning phase would
give false positive results [4]. In this study, sensitivity of
detecting a tumour was 76% and speciﬁcity only 33%.
Radiological examination underestimated the size of the
tumour (≤5 mm) when compared with the intraoperative
ﬁnding (6–10 mm). Despite the exceptional sensitivity of SPGR,
precise tumour targeting is not possible.
Our goal was to prove that targeting was possible using a
combination of state-of-the-art methods. Accordingly, we
used a combination of preoperative MR (SE, SPGR, fSPGR),
neuronavigation and iMRI. For pituitary adenoma depiction
we followed current recommendations [25–27]. To a standard
SE sequence we added SPGR, fSPGR sequences and analysis of
their combinations. The study was surgically focused. Wheth-
er the data about the shape of the adenoma can help surgeon
in resection of the adenoma. Aside of the presented sequences
we used the sequences as recommended by the current review
paper on this topic [28]. Therefore we do not discuss in this
paper value of diffusion weighted imaging or perfusion
weighted imaging in sellar region.
We achieved 100% sensitivity. Particularly noteworthy is
that we cooperated with only one department that performs
endocrinological examinations, namely the 3rd Medical
Department of the 1st Medical Faculty, Charles University.
Increased sensitivity could be attributed to the combination of
all three MR sequences (SE, SPGR and fSPGR). Using these three
sequences, a skilled neuroradiologist with more than 20 years
of clinical practice was able to identify tumours in all cases, as
well as to deﬁne the extent of the tumours and to properly set
neuronavigation software. The main issue of speciﬁcity of
these MR sequences remains.For statistical analysis, each sampling area was shared and
compared with similar areas of histological positivity. We
searched the place of compliance in individual locations.
There was a consensus in individual locations in 63 of the 123
cases (56%). The correlation gamma function at a 5%
signiﬁcance level was then 0.27. This result translates to a
speciﬁcity of 56%. The speciﬁcity is the certainty of ﬁnding a
pituitary adenoma at the measuring point. Overall, we are able
to increase speciﬁcity by a combination of methods speciﬁcity
of 33% (according to literature) at 56%. Complete agreement,
i.e. compliance in all combinations, was achieved in only 20%
of the cases. This is the overlap of the tumour outside the
viewing area, or conversely, larger ﬁndings displayed on MR
than ﬁndings on postoperative histology. This observation is
consistent with the authors of the above-mentioned publica-
tions.
If we examine individual ﬁndings in our cohort, full
concordance of results was attained in eight patients (20%).
In 21 patients (51%), histological ﬁndings were more extensive
than MR imaging, i.e. positive histology samples were found
beyond the supposed limits deﬁned by MRI. The opposite
result, i.e. histological extent smaller than MRI extent,
occurred in three patients (7%). Negative speciﬁcity was noted
in nine patients (22%). In these cases, the extent of MRI differed
from the histological ﬁnding. The role played by the number of
patients, not statistical consensus at individual points.
Important is the correlation of MRI, histology and endo-
crinological outcome after surgery. In our study, remission of
morning cortisol hypersecretion during the follow-up was
achieved in case of the full agreement between MRI and
histology in 100%. In this subgroup of complete concordance,
the level of morning cortisol was 23–462 nmol/l.
In case of more extensive histological ﬁndings than what
would be suspected on MRI, morning cortisol hypersecretion
was achieved in 21 patients (90%), with serum levels reaching
6–551 nmol/l. There was the borderline between tumour and
healthy adenohypophysis was distinct. The tumour was
resected beyond the area shown on MRI. As a result, these
surgeries led to high radicality of resection. On the other hand,
less extensive histology ﬁndings (i.e. there were negative
samples taken in place of MRI ﬁndings) were found in three
patients (7%). If the histology were less extensive (i.e. there
were negative samples taken in place of MRI ﬁndings or there
were no positive samples), then there was endocrinological
remission in 1 of the 3 cases (33%). There may also include a
suitable place of sampling or an insufﬁciently transparent area
to continue resection. Patients with sinus tumour inﬁltration
belong to this group of patients. The overall result (i.e. the
extinction morning serum cortisol activity) reached 88% in our
group in the follow-up period.
Evidence shows that endocrinological remission after
transsphenoidal surgery in Cushing's disease ranges from
79.5% to 89% [29,30]. iMRI led to a decision to continue with
resection in one case (2.5%). Overall radicality is inﬂuenced by
the relatively short follow-up time, which was 6–42 months in
our study. We assume that the natural course of the disease
will decrease radicality with time. In our cohort, two patients
with high cortisol levels are on hormonal therapy, two patients
were irradiated by LGK and one unsuccessfully irradiated
patient underwent adrenalectomy.
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patients, who subsequently underwent revision surgery,
including CSF ﬁstula closure and lumbar drainage insertion.
One patient with a chronic sphenoid sinus infection suffered
postoperative meningitis without CSF leakage and was treated
by antibiotics without need for surgical intervention.
Overall, mortality was 0% and morbidity 7.3% in our cohort.
If we include long-term substitution of vasopressin analogue,
morbidity reached 14.6%.
5. Conclusion
The aim of our study was an optimisation of preoperative MR
diagnostic protocol in Cushing's disease and to prove its
increased diagnostic yield in a prospective trial. Recent studies
have shown sensitivity to be 76%, whereas speciﬁcity of exact
tumour localisation has only been 33%. Our effort was to use a
combination of modern diagnostic methods and to show that
exact tumour localisation is possible. Combination of MR
sequences (SE, SPGR, fSPGR), a neuronavigation system and
iMRI resulted in an increase in sensitivity (up to 100%).
Speciﬁcity reached as high as 56% in our study. We found a
high success rate in surgical procedure in terms of the
correlation between MR ﬁndings and histology, which leads
to remission of Cushing's disease. Our results support the use
of MR examination together with a navigation system and
iMRI.
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